We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 5.85 | 372,423 | 08:00:04 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 5.70 | 6.00 | 5.95 | 5.85 | 5.95 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Miscellaneous Metal Ores,nec | 19.4M | -3.29M | -0.0051 | -11.47 | 37.53M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:26:36 | O | 119 | 5.988 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 17/2/2025 | 17:36 | ALNC |  IN BRIEF: Kromek eyes profitability after receiving Siemens payment |
| 17/2/2025 | 07:19 | ALNC | *Kromek to receive further USD12.5m from Siemens Healthineers over next.. |
| 17/2/2025 | 07:00 | UK RNS | Kromek Group PLC $25m received under Siemens Healthineers agreement |
| 07/2/2025 | 13:49 | UK RNS | Kromek Group PLC Holding(s) in Company |
| 06/2/2025 | 12:35 | UK RNS | Kromek Group PLC Holding(s) in Company |
| 31/1/2025 | 20:00 | ALNC | IN BRIEF: Kromek signs Siemens deal; sees brighter profit view |
| 30/1/2025 | 07:01 | UK RNS | Kromek Group PLC Interim Results |
| 30/1/2025 | 07:00 | UK RNS | Kromek Group PLC Kromek Signs Agreements with Siemens Healthineers |
| 13/12/2024 | 12:20 | UK RNS | Kromek Group PLC Result of AGM |
| 18/11/2024 | 07:00 | UK RNS | Kromek Group PLC Notice of AGM and Publication of Annual Report |
Kromek (KMK) Share Charts1 Year Kromek Chart |
|
1 Month Kromek Chart |
Intraday Kromek Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 13/3/2025 | 09:52 | Kromek Group PLC | 7,424 |
| 05/1/2022 | 09:19 | Kromek Group (KMK) - Overvalued AIM mugging | 182 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 16:26:37 | 5.99 | 119 | 7.13 | O |
| 15:46:08 | 5.99 | 83 | 4.97 | O |
| 15:02:32 | 5.70 | 85 | 4.85 | O |
| 15:02:32 | 6.00 | 4,883 | 292.98 | O |
| 15:02:32 | 6.00 | 20 | 1.20 | O |
| Top Posts |
|---|
Posted at 19/3/2025 08:20 by Kromek Daily Update Kromek Group Plc is listed in the Miscellaneous Metal Ores,nec sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 5.85p.Kromek currently has 641,550,000 shares in issue. The market capitalisation of Kromek is £37,530,675. Kromek has a price to earnings ratio (PE ratio) of -11.47. This morning KMK shares opened at 5.95p |
Posted at 06/3/2025 13:27 by jaknife Cry baby cyberdyne1,"I reiterate my point Kromek or the house broker have not put any figures (yet) against the supply agreement. This is not factored into any projections. Once the Company gets a time-line and order book for CZT tiles under the supply agreement they will be able to issue revised forecasts and issue guidance to the analysts at Cavendish for them to make their own projections. The one fact they we do know is the supply will happen, otherwise Siemens $37m will have been wasted." FFS what is wrong with you? Cavendish published their latest comments on 17th February. This was more than two weeks *AFTER* the Siemens deal was announced! The numbers are identical to those from their 30th January report, which was produced in conjunction with the announcement of the Siemens deal and the release of the interims. The report explicitly states that they have been updated to allow for the Siemens deal. Everything can be downloaded for free from: Please don't waste my time responding with your nonsense. Read the reports, confirm what I've written, and then come back and apologise profusely. And let's not forget, you promised everyone 8p by yesterday but actually the share price is (now) down 14% from the 6.8p that it was when you first made your bold prediction. FWIW, at 5.85p, KMK still trades at a whopping 36.6x Kromek's 2027 fwd forecast EPS of 0.16p! JakNife |
Posted at 06/3/2025 11:35 by jaknife Cry baby cyberdyne1,"Sorry to disappoint you JakNife but I have used the last week or so to accumulate." 1. I wish you the best of luck. But, as I frequently find myself pointing out, luck does not equate to an investment strategy, it is simply gambling! "The forward multiples you quote are of course outdated." 2. Posting comments like this only serves to confirm that you haven't even bothered to read the most recent broker update. That's pretty shocking given that the house broker's research is available for free online: The most recent house broker (Cavendish) forecasts are dated 17th February and take into account the Siemens deal. Read them and you will see that a profit is made from the initial sale to Siemens but that the profit then materially tails off: Year PBT (forecast) EPS (p)2025 £4.9 0.772026 £2.1 0.342027 £1.0 0.16 Taking last night's closing share price of 6p and dividing by the 2027 fwd forecast EPS of 0.16p gives a PE ratio of 37.5x, ie exactly as I have posted above in post no. 7,416. Don't you think that you should actually do *some* research before posting? "The year end financials wont of course include the Siemens supply agreement income but the 2026 and 2027 and beyond will. This is a relatively medium to long term hold for me and always was." I remind you that you arrogantly posted two weeks ago that longs could expect at least 8p by now. You also maliciously libelled me a month ago claiming that I posted "miss-information" - we find out now that you can't even be bothered to read a free house broker report to even know what the current "information" is. What is a "relatively medium to long term hold" investment? A short term investment that went wrong! JakNife |
Posted at 05/3/2025 16:58 by jaknife Cry baby cyberdyne1,Two weeks ago you posted: ==================== 19 Feb '25 - 10:17 - 7401 of 7412 Don’t write it off quite so quickly. I’m sure in a week or two we will be in the 8’s. ==================== KMK isn't "in the 8’s", in fact it's fallen 11.8% compared to two weeks ago. However, even at this price KMK trades on 37.5x 2027 fwd forecast EPS, which still makes it look expensive. I assume that you've dumped your KMK and exercised a stop loss? What else does one do when an investment thesis fails? Let it become a "long term investment" (*)? JakNife * - A short term investment that went wrong! |
Posted at 06/2/2025 13:16 by jaknife Dannymaz89,David newlands Guy is 800% up in his FTC tr1 and 500% on his AET tr1 Todays buys says he’s not done imo ? The dorkus first announced a position in KMK on 21 April 2021: Back then the share price was 15.5p! So he's 60%+ down on his initial purchase and averaging down. He's yet another person that has been suckered into getting long by the siren calls of Arnab Basu. FFS! You're looking for Confirmation Bias ( in every RNS that you read instead of actually reading, thinking and working out an opinion for yourself! JakNife |
Posted at 06/2/2025 12:53 by cyberdyne1 Boomboy - I appreciate you are a LT holder and underwater and sceptical. However JakNife works hard against the price rise that you need. His aim is to sow miss-information and despair to deter new investors and holders alike to get the price to drop. I’ve been holding a few months not the days/weeks you indicate. If you genuinely want a share price rise JakNife isn’t the solution but part of the problem |
Posted at 06/2/2025 01:15 by b00mb0y I concur, jaknife.I would think, though I don’t know, that cyberdyne1 has only recently bought in on KMK since the RNS and if so, then he/she is down already. He/she is averaging down as the price drops awaiting for that big jump. Fair play. I’ve done exactly the same since IPO (13 years) and as of today I need at least a 200% increase from here for breakeven. All long term holders have endured the fantastic KMK RNS’s since the IPO only to see their investment consistently decline. The share price trend line since IPO confirms that. I, along with any of the other LTH’s that are left, am only hoping that this time is going to be the turnaround that has been so long in coming. Fingers, toes and everything else are crossed but I can not hold my breath. Just saying. |
Posted at 01/2/2025 11:55 by jaknife pilkers,"With the siemens contract now in place valued only slightly below the current market cap this now derisks kmk as a takeover target." What a load of complete nonsense. Have you read the background in the posts above? Kromek did a $58m deal with Siemens back in January 2019: 1. They weren't a takeover target then and weren't taken over in any of the following six years. 2. In 2020, the year immediately after the big deal, Kromek reported its largest net loss out of all of the losses that it's reported in the last six years Year Loss2019 £0.62020 £16.52021 £5.42022 £4.92023 £6.12024 £3.3 Kromek has reported a loss *EVERY* year that it's been listed which means it reported losses in *EVERY* year following the last deal with Siemens. 3. Get your hands on the Cavendish forecasts. Cavendish are the house broker and yes, they do forecast a profit for the current fiscal year. But can you see what happens in the years after? Year PBT (forecast) EPS (p)2025 £4.9 0.772026 £2.1 0.342027 £1.0 0.16 Cavendish forecast that a profit is made from the initial sale but that profit then materially tails off. I would bet money that Cavendish have thrown a bit of optimism into their 2026 and 2027 numbers and that actually those years will return to form and be loss-making ones. Summary The Siemens deal is described as a "four-year" deal and the house broker, Cavendish, has adjusted its forecasts to predict TOTAL profits (from *ALL* business inc Siemens) over the next three years of £8m, of which a big chunk of those profits are one-off in 2025 and 2026. Looking at the closing share price of 6.4p, and Cavendish's 2027 EPS forecast of 0.16p, KMK is trading on a forward EPS of 40x!!!!! It's not cheap by a long long way. Retail punters have got far too excited about Kromek and its deal with Siemens. The reality is that its main importance to Kromek is that it has saved it from insolvency. Without this deal Kromek was running out of cash fast and would have needed a rescue placing. As it is, Cavendish forecast closing net cash for Kromek of just £1.8m as at April 2025. It's not a big number and it probably won't be long before KMK is back in debt once again! Now you know why so many have been selling heavily into the recent share price excitement! JakNife |
Posted at 31/1/2025 13:27 by jaknife Reabank,Siemens is an existing customer, they've been involved with KMK for ages. There was much speculation that this contract, for example, was Siemens: And given the CEO's previous involvement it always made sense. It would also make sense that that deal is getting to the end of its terms and needs to be replaced by a new one. Notice how that deal was announced with a fan-fare "expected to be worth a minimum of $58.1m over a seven-year period"? Management are always quick to announce contract wins but: A. Those contracts have NEVER been profitable (KMK has been loss-making since it first listed in Oct 2013), and B. Management are quick to announce contract wins but NEVER announce the contract losses. Total revenue over the last 5.5 years has been £76m (c. $95m). Assuming uniformity of the original contract then Siemens have been 50% of KMK's business for those 5.5 years. If Siemens are basically buying everything that they need to replace KMK and make CZT detectors themselves then the business that's left is half the size of what it was. KMK has been hopelessly loss-making ever since it listed, so a "50% of KMK" business is going to be even more hopelessly loss-making! JakNife |
Posted at 30/1/2025 13:03 by jaknife The results are awful.P&L 1. Revenue is down 48.2%! Can anyone point to the RNS where Kromek warned that revenues were going to drop materially? I can see loads of RNSs about new contracts but there's not one warning that contracts have been lost or that revenue is going to fall materially. 2. Costs are up! How on earth can distribution costs be up when revenue has nearly halved? That suggests 100% inflation in distribution costs!?!?! Why are Admin expenses up 8%? 3. Costs hidden in the P&L Note that a further £2.2m of costs have been capitalised directly to the cash flow statement 4. Total loss of £8.9m for the first six month of the year if you include the capitalised costs. Is the company on track for a full-year loss of £18m? Balance Sheet 1. Tangible net assets are just £8.6m, cf the market cap at pixel (6.75p share price) is £43.3m! 2. Why are inventories so high at £11.1m when H1 cost of sales was just £1.6m? On the face of it they're carrying the equivalent of 3.5 years' worth of stock?!?! Have they got a problem with excess stock or stock that needs to be written off? 3. Why are trade and receivables so high at £9.3m? H1 revenue was only £3.6m! That must means that invoices issued a year ago still haven't been paid? Have they got a problem with customers not paying them? 4. Net debt as at 31 October was £11.7m. They signed a loan agreement around about that date, what is net debt today? Note 14 to the accounts shows that a further £1m loan was required since October Cash Flow Note 10 show the normal cash flow statement. There's a large swing in working capital that has been favourable to KMK. That looks like a one-off that can't be repeated. The Siemens Deal 1. The interims note: ”the first installment of $25.0m to be received in the current financial year, of which a material amount will be recognised as revenue” Why only “a material amount”, why not all of it? 2. They also note "The initial $25.0m payment from Siemens Healthineers will be used to support the delivery of various milestones under the agreements,” What are the costs associated with the Siemens deal? KMK’s costs of sales is 43% of revenue (ie the gross profit margin is 57%). So should we assume that the cost of sales for the Siemens deal is 43% of $25m? If so then gross profit would be just $14.25m, which is £11.5m in sterling terms, which is only just enough to pay off the debt!!! Conclusion Yet again Kromek’s CEO has demonstrated that he is an untrustworthy crook. He publishes RNSs left right and centre telling shareholders about contract wins but doesn’t provide *ANY* information about contract losses and doesn’t bother to warn when revenues fall off of a cliff. Revenues are dwarfed by enormous administration expenses and further costs are hidden in the cash flow statement and no details are given about the costs associated with the $25m due from Siemens this year, leaving shareholders to fill in the gaps on what the net amount might be. Shareholders have got carried away with a one-off deal. Six months from now, after the normal cycle of excessive costs (including rewards for failure to the directors) the balance sheet will likely have improved marginally to perhaps £13m (net tangible assets), which would be 2p a share – a much more reasonable price given the dishonesty that management displays. JakNife |
Posted at 09/5/2023 19:21 by aqc888 For some context;Pivotal year unfolding for Kromek - 18/1/22 Share price 14.5p Winners in an uncertain world - 16/5/22 Share price 9.7p Kromek’s record sales visibility is materially undervalued - 2/8/22 Share price 9.5p A biological detection winner - 11/22 Share price 8.75p This stock is about to turn world-leading technology into profit - 2/23 Analysts think this stock's share price will quadruple - 4/23 Share price 6.85p Buy into Kromek's £7.5mn open offer of new shares - today Share price 5p …. It goes back way further when share price was way way higher… “Don't worry about Kromek's revenue fall“ - 1/2019 Share price 26p |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
